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A genome wide survey supports the involvement of large copy number variants in 
mental retardation and comorbid psychiatric disorders
Abstract
CNVs play a role in mental retardation and neuropsychiatric disorders  (e.g., 
schizophrenia and autism). Consistent with high rates of comorbid diagnoses, a 
large overlap in the specific CNVs that play a role has been reported. The aims of 
this study are: i) to examine the contribution of very large (>1Mb) CNVs in the total 
mental retardation sample (N=170); ii) to compare the global CNV burden between 
64 subjects with mental retardation and schizophrenia (“MR+SCZ”) and 65 subjects 
with mental retardation and no comorbid psychiatric diagnosis except depression 
(“MR only”); iii) to assess the CNV rates in 12 candidate regions for 
neurodevelopmental disorders.
Background and aims
Patients were over 18 years of age, with an IQ of <70 and were recruited from the 
inpatient and outpatient services for Adults with Learning Disability (MR) of SE 
Scotland Health Boards.  Mental health diagnoses were reached according to 
DSM-IV criteria using a semi structured interview.Genotype data were available 
from 182 subjects. The final sample after excluding subjects based on quality 
control criteria comprised 170 subjects. A comorbid diagnosis of major psychiatric 
illness was present in 100 subjects: schizophrenia (N=64), bipolar disorder (N=21), 
major depressive disorder (N=15); and 19 subjects were diagnosed with autism. 
Samples were genotyped on three plates by the Broad Institute using the Affymetrix 
6.0 array which includes 906,600 SNP and 940,000 copy number probes. CNVs 




Candidate regions for neurodevelopmental disorders are significantly enriched with 
the large CNVs detected in this study. Furthermore, the CNV burden for large 
(>1Mb) CNVs is increased in patients with mental retardation and comorbid 
schizophrenia compared to patients with mental retardation only. We replicated the 
role of CNVs in regions 1q21.1, 15q13.1, 16p13.1, and 22q11.21 in causing mental 
retardation with or without psychiatric comorbidity. 
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Including all CNVs larger than 100kb, CNV burden (total, deletions, and 
duplications) was similar in “MR+SCZ” and “MR only”. Restricting analysis to 
CNVs larger than 1Mb, total CNV burden was higher in “MR+SCZ” (rate=.25) 
compared to “MR only” (rate=.09; empirical p=.03). Seven of the 33 large CNVs 
were located at candidate regions 1q21.1, 15q13.1, 16p13.1, and 22q11.21 which 
is a significant enrichment of the candidate regions (p=.002). 
Table 1	   Overview of CNV data (>100kb) in 170 subjects with mental retardation (MR) and a 
	   comparison by schizophrenia status
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N (rate)Total CNV 1791 (10.5) 663 (10.4) 678 (10.3) .92
N (rate) Deletions 780 (4.6) 281 (4.4) 316 (4.8) .49








N (rate) Total CNV 33 (.19) 16 (.25) 6 (.09) .03
N (rate) Deletions 15 (.09) 6 (.09) 5 (.08) .47
N (rate) Duplications 18 (.11) 10 (.16) 1 (.02) .01
Table 2	   Overview of CNV data (>1Mb) in 170 subjects with mental retardation (MR) and a 
	   comparison by schizophrenia status
Copy Number Variants (CNVs) play a role in mental retardation and 
neuropsychiatric disorders. The aim of this study is to investigate the contribution of 
large CNVs to mental retardation (MR) and to report on CNV burden in  MR with 
and without comorbid schizophrenia (SCZ). Subjects with MR+SCZ showed 
significantly more large (>1Mb) duplications compared to subjects with MR only. We 
replicated the role of CNVs in regions 1q21.1, 15q13.1, 16p13.1, and 22q11.21 in 
causing mental retardation with or without psychiatric comorbidity. 
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